Stevanato Group (NYSE:STVN) Shares Down 8.5% on Analyst Downgrade

Shares of Stevanato Group S.p.A. (NYSE:STVN) dropped 8.5% on Thursday after Citigroup lowered their price target on the stock from $32.00 to $26.00. Citigroup currently has a buy rating on the stock. Stevanato Group traded as low as €16.02 and last traded at €16.01. Approximately 194,477 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 736,905 shares. The stock had previously closed at €17.50.

STVN has been the topic of several other reports. KeyCorp dropped their price target on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday. Morgan Stanley initiated coverage on shares of Stevanato Group in a research note on Monday, December 1st. They issued an “equal weight” rating and a $24.00 price objective for the company. Jefferies Financial Group set a $17.50 target price on shares of Stevanato Group in a research note on Tuesday, February 10th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stevanato Group in a research note on Monday, December 29th. Finally, Wall Street Zen cut shares of Stevanato Group from a “buy” rating to a “hold” rating in a research report on Saturday, February 14th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Stevanato Group News Summary

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Q4 results showed revenue growth and an EPS beat (roughly €0.21 vs. ~€0.20 expected), with quarterly revenue of €346.5m and expanded margins — news that initially supported upside in the stock. Stevanato Group SpA (STVN) Q4 2025 Earnings Call Highlights
• Positive Sentiment: Full‑year 2025: revenue +7% (9% at constant currency) and record revenue from higher‑value solutions, evidence of continued product mix improvement and margin leverage. Stevanato Group Delivers 7% Revenue Growth for Fiscal Year 2025
• Positive Sentiment: The company outlined a 2026 revenue target (up to ~€1.308B) and expects high‑value solutions to reach roughly 48% of sales — a strategic growth driver that supports longer‑term earnings potential. Stevanato Group outlines 2026 revenue target up to €1.308B
• Neutral Sentiment: Management issued FY‑2026 EPS guidance of €0.690–0.730 (consensus ~0.730) and revenue guidance roughly in line with street expectations — guidance is cautious and offsets some of the positive beats. Stevanato FY‑2026 Guidance (slide deck/press release)
• Neutral Sentiment: Full Q4 / FY call transcripts and coverage are available for more detail on backlog, mix and capex — useful for assessing sustainability of the high‑value mix shift. Q4 2025 Earnings Call Transcript
• Negative Sentiment: Two analyst price‑target cuts arrived: KeyCorp trimmed its PT to $32 (from $37; overweight) and Citigroup cut its PT to $26 (from $32; buy). These downgrades likely pressured the stock despite positive results. KeyBanc PT Lowered to $32 Citigroup PT Cut (Benzinga)
• Negative Sentiment: Market technicals and price action are weak: the stock is trading below its 50‑ and 200‑day moving averages and volume was higher than average, consistent with a selling reaction after the mixed guidance/analyst actions. Market data and technicals (MarketBeat)

Institutional Investors Weigh In On Stevanato Group

Institutional investors and hedge funds have recently made changes to their positions in the business. Royal Bank of Canada boosted its stake in Stevanato Group by 10.8% during the 1st quarter. Royal Bank of Canada now owns 437,284 shares of the company’s stock valued at $8,930,000 after purchasing an additional 42,731 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of Stevanato Group by 4.4% in the second quarter. Envestnet Asset Management Inc. now owns 170,002 shares of the company’s stock valued at $4,153,000 after purchasing an additional 7,232 shares in the last quarter. First Horizon Advisors Inc. boosted its position in shares of Stevanato Group by 14.9% during the second quarter. First Horizon Advisors Inc. now owns 3,833 shares of the company’s stock valued at $94,000 after buying an additional 497 shares during the last quarter. Marco Investment Management LLC bought a new stake in Stevanato Group during the second quarter worth $228,000. Finally, Zions Bancorporation National Association UT grew its holdings in Stevanato Group by 9.2% during the second quarter. Zions Bancorporation National Association UT now owns 102,357 shares of the company’s stock worth $2,501,000 after buying an additional 8,648 shares in the last quarter.

Stevanato Group Price Performance

The company has a current ratio of 1.89, a quick ratio of 1.30 and a debt-to-equity ratio of 0.26. The business has a 50-day moving average of €17.69 and a 200 day moving average of €21.71. The firm has a market capitalization of $4.84 billion, a PE ratio of 27.55, a price-to-earnings-growth ratio of 1.44 and a beta of 0.57.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.